from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1304/atpB

LFCtreatmentdescriptionclass of inhibitor

-1.822

Amikacinug/mL Amikacintranslation

-1.039

Cap5-10ug/mL Capreomycintranslation

-1.681

Rox10-50 ug/mL Roxithromycintranslation

-0.134

SM2-5 ug/mL Streptomycintranslation

-2.253

Tet5-10 ug/mL Tetracyclinetranslation

-0.994

Rif0.2-5ug/mL Rifampicintranscription

-1.356

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.522

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.074

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.043

CPZ10-50 ug/mL Chlorpromazinerespiration

0.380

Clofazimine10-13 ug/mL Clofaziminerespiration

0.959

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.528

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.608

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.370

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.904

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.324

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.840

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.798

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.430

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.261

KCN5-20 ug/mL Potassium cyaniderespiration

1.085

NaN30.2-2 mM Sodium aziderespiration

0.003

Nigericin50 uM Nigericinrespiration

-0.780

TRC10-150 ug/mL Triclosanrespiration

-1.254

TRZ10-25 ug/mL Thioridazinerespiration

-2.542

Valinomycin0.5-10 uM Valinomycinrespiration

1.030

ZnSO42 mM ZnSO4respiration

-0.804

menadione6-10 ug/mL Menadionerespiration

0.027

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.616

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.280

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.746

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.379

NRP_1Non-replicating persistence stage 1dosRassociated

0.871

Amp0.2mg/mL AmpicillincellWall

0.460

Cephalexin20-100 ug/mL CephalexincellWall

0.430

Cerulenin0.32-5 ug/mL CerulenincellWall

0.711

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.209

EMB10-20 ug/mL EthambutolcellWall

0.667

Eta12-40 ug/mL EthionamidecellWall

0.439

INH0.2-0.4 ug/mL IsoniazidcellWall

0.583

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.581

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.659

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.227

BZA0.12 mg/mL BenzamidearomaticAmides

-0.058

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.361

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.477

H2O24 mM hydrogen peroxideDNAdamaging

0.893

Levo10 ug/mL LevofloxacinDNAdamaging

1.021

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.441

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.525

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.826

UVUV-irradiationDNAdamaging

-1.874

ARP41-4 ug/mL Antitubercular compound ARP4?

0.549

Antimycin12.5-50 ug/mL Antimycin A?

0.023

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.079

PA_110-50 ug/mL Antitubercular compound PA-1?

1.209

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.910

PA8240.2-2 ug/mL PA-824?

-0.352

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.024

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.181

Verapamil50 uM Verapamil?

0.117

mercaptoethanol2 mM 2-Mercaptoethanol?

0.495

methoxatin10-20 ug/mL Methoxatin?